trial · primary record
Allopurinol
B Acute Lymphoblastic Leukemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 303 |
| Primary completion | 2028-04-01 |
| Primary endpoint | Event-free survival (EFS) |
| Registry ID | NCT03150693 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:26.724Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03150693
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.